These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35309091)

  • 1. Ecstasy (MDMA): A rebellion coherent with the system.
    García-Montes JM; Pérez-Álvarez M; Sánchez-Moya MÁ; Torres JAC; Carreno DF; Garcelán SP; Sánchez-Sánchez LDC
    Nordisk Alkohol Nark; 2021 Feb; 38(1):89-102. PubMed ID: 35309091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From ecstasy to MDMA: Recreational drug use, symbolic boundaries, and drug trends.
    Edland-Gryt M; Sandberg S; Pedersen W
    Int J Drug Policy; 2017 Dec; 50():1-8. PubMed ID: 28869878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
    McCaughan JA; Carlson RG; Falck RS; Siegal HA
    Subst Use Misuse; 2005; 40(9-10):1503-23. PubMed ID: 16048830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
    J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.
    Yacoubian GS; Boyle C; Harding CA; Loftus EA
    J Drug Educ; 2003; 33(2):187-96. PubMed ID: 12929709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploration of recent club drug use among rave attendees.
    Yacoubian GS; Peters RJ
    J Drug Educ; 2007; 37(2):145-61. PubMed ID: 17977238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Detection of Novel Stimulants in Oral Fluid from Users Reporting Ecstasy, Molly and MDMA Ingestion.
    Krotulski AJ; Mohr ALA; Fogarty MF; Logan BK
    J Anal Toxicol; 2018 Oct; 42(8):544-553. PubMed ID: 30371847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of ecstasy use amongst live music event attendees and their opinions on pill testing: a cross sectional study.
    Southey M; Kathirgamalingam A; Crawford B; Kaul R; McNamara J; John-Leader F; Heslop J; Pit SW
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):55. PubMed ID: 32758263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of acute psychotic episode after a single dose of ecstasy].
    Vaiva G; Bailly D; Boss V; Thomas P; Lestavel P; Goudemand M
    Encephale; 2001; 27(2):198-202. PubMed ID: 11407274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.
    Carlson RG; Falck RS; McCaughan JA; Siegal HA
    J Psychoactive Drugs; 2004 Jun; 36(2):181-9. PubMed ID: 15369199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of mild hyponatraemia in females using ecstasy at a rave party.
    van Dijken GD; Blom RE; Hené RJ; Boer WH; NIGRAM Consortium
    Nephrol Dial Transplant; 2013 Sep; 28(9):2277-83. PubMed ID: 23476039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Club drug use in Germany.
    Soellner R
    Subst Use Misuse; 2005; 40(9-10):1279-93. PubMed ID: 16048817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward an ecstasy and other club drug (EOCD) prevention intervention for rave attendees.
    Yacoubian GS; Miller S; Pianim S; Kunz M; Orrick E; Link T; Palacios WR; Peters RJ
    J Drug Educ; 2004; 34(1):41-59. PubMed ID: 15468747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.
    Zhao H; Brenneisen R; Scholer A; McNally AJ; ElSohly MA; Murphy TP; Salamone SJ
    J Anal Toxicol; 2001; 25(4):258-69. PubMed ID: 11386639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysubstance use patterns in underground rave attenders: a cluster analysis.
    Fernandez-Calderón F; Lozano OM; Vidal C; Ortega JG; Vergara E; González-Sáiz F; Bilbao I; Caluente M; Cano T; Cid F; Dominguez C; Izquierdo E; Pérez MI
    J Drug Educ; 2011; 41(2):183-202. PubMed ID: 21888000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raves, drugs and experience: drug use by a sample of people who attend raves in Western Australia.
    Lenton S; Boys A; Norcross K
    Addiction; 1997 Oct; 92(10):1327-37. PubMed ID: 9489049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
    Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A profile of Ecstasy (MDMA) use in São Paulo, Brazil: an ethnographic study.
    Battisti MC; Noto AR; Nappo S; Carlini Ede A
    J Psychoactive Drugs; 2006 Mar; 38(1):13-8. PubMed ID: 16681171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves.
    Parrott AC
    Neuropsychobiology; 2004; 50(4):329-35. PubMed ID: 15539865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.